ACE-167

What is ACE-167?

ACE-167 is an investigational, synthetic peptide reference compound developed for preclinical evaluation across endocrinology, metabolic disease, and reproductive system models. Engineered as a stable peptide agent, ACE-167 targets key signaling pathways governing hypothalamic-pituitary-gonadal (HPG) axis balance, endogenous testosterone production, and skeletal muscle protein preservation during catabolic states.

Batch-verified for high analytical purity at NobleChems, ACE-167 is supplied in a pre-measured 2.5MG dry-fill oral capsule format (60 units per bottle). Researchers investigating endocrine recovery, anabolic-catabolic nitrogen balance, and metabolic disease pathways utilize ACE-167 alongside related endocrine and peptide reference standards available on the site, such as Enclomiphene and SLU-PP-332.

Chemical and Molecular Data

What are the Mechanisms of Action?

The biochemical pathways and cellular targets:

• HPG Axis Modulation & Endogenous Testosterone Stimulation: Research demonstrates ACE-167 interactions with central gonadotropic signaling cascades. In cell culture models, it promotes the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) precursors, stimulating Leydig cell testosterone biosynthesis without inducing negative-feedback testicular atrophy.

• Anti-Cachectic Action & Muscle Protein Preservation: Suppression of ubiquitin-ligase expression and blocks catabolic muscle degradation pathways. By modulating Akt/mTOR phosphorylation in skeletal muscle tissue assays, it helps preserve myocyte structural integrity during inflammatory or metabolic strain.

• Metabolic Homeostasis & Lipid Metabolism: In metabolic dysfunction models, basal glucose oxidation and hepatic lipid clearance provide an effective reference tool for studying non-alcoholic fatty liver states and metabolic syndrome parameters.

What do Preclinical & Academic Studies Show?

When evaluating research efficacy and published scientific literature:

• Preclinical Endocrine Pipeline Profile (AdisInsight): Detailed drug profiling cataloged on AdisInsight (Springer) highlights ACE-167 as a synthetic peptide evaluated for hypogonadism, Klinefelter syndrome, cachexia, and metabolic disease indications.

• Therapeutic Mapping & Patent Data (Patsnap Synapse): Comprehensive translational research archived on Patsnap Synapse documents active R&D focus in endocrinology, non-alcoholic fatty liver disease, and immune system tissue models.

• Peptide-Based Anti-Atrophy Mechanisms (PMC): Comparative biomedical literature archived in PMC (PMC8919388) evaluates short-chain synthetic peptides for dampening myostatin/TGF-β catabolic signaling and restoring muscle mass in cachectic disease models.

How does ACE-167 compare to other compounds?

To evaluate endocrine receptor targeting, anabolic potency, and metabolic pathways, researchers compare ACE-167 against alternative reference standards available at NobleChems:

Frequently Asked Questions (FAQs)

1. Is NobleChems a reliable place to buy ACE-167?

Yes, NobleChems is a highly trusted vendor for high-purity research chemicals and peptide reference standards. Every batch undergoes rigorous third-party analytical testing (including HPLC and Mass Spectrometry) to verify minimum 98%+ purity, correct sequence identity, and complete absence of heavy metals or synthetic impurities.

2. What is the primary research focus of ACE-167?

ACE-167 is researched primarily as an endocrine and metabolic modulator. Laboratory studies evaluate its role in treating hypogonadism models, mitigating cachectic muscle wasting, and regulating glucose and lipid parameters in non-alcoholic fatty liver models.

3. How does ACE-167 modulate the hypothalamic-pituitary-gonadal (HPG) axis in vitro?

Via central endocrine receptors to promote endogenous gonadotropin release. In testicular cell culture assays, this signaling cascade supports Leydig cell enzymatic activity, stimulating endogenous testosterone biosynthesis.

4. What role does ACE-167 play in muscle wasting and cachexia research?

In muscle cell lines, it suppresses ubiquitin-ligase enzymes responsible for protein degradation while stimulating Akt phosphorylation. This dual action helps maintain muscle fiber size and protein density under catabolic stress.

5. What are the advantages of NobleChems’ 2.5MG dry-fill capsule format?

NobleChems is provided in pre-measured 2.5MG dry-fill solid capsules (60 units per bottle). This format ensures exact unit-mass accuracy for solid-state laboratory assays, preventing weighing errors and eliminating reconstitution handling variance.

6. How does ACE-167 differ from direct androgen receptor agonists or exogenous testosterone?

Exogenous testosterone directly activates androgen receptors and triggers severe negative feedback, suppressing natural LH/FSH production. It acts as a peptide modulator that supports natural endocrine signaling and tissue preservation without suppressing central pituitary function.

7. How does ACE-167 compare to Enclomiphene in endocrine research?

Enclomiphene is a nonsteroidal SERM that works exclusively by blocking pituitary estrogen receptors to increase LH and FSH. ACE-167 is a synthetic peptide that combines endocrine axis stimulation with direct anti-cachectic and metabolic protective signaling.

8. What are the recommended storage parameters for capsules?

Bottles containing dry-fill capsules should be stored tightly sealed in a cool, dry environment (15°C to 25°C) away from direct sunlight, excess heat, and humidity. Stored under controlled room conditions, capsules maintain full chemical stability throughout their designated shelf life.

Disclaimer: All compounds and research materials provided by NobleChems are strictly for laboratory and research professional use only. They are not approved for human or animal use nor consumption by the Food and Drug Administration (FDA). These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.